Ritlecitinib for treating severe alopecia areata in people 12 years and over

Ritlecitinib (Litfulo, Pfizer) is indicated for 'the treatment of severe alopecia areata in adults and adolescents 12 years of age and older'.

The dosage schedule is available in the summary of product characteristics for ritlecitinib.

Ritlecitinib costs £949.41 per pack of 30 capsules (dictionary of medicines and devices, accessed February 2024).

The company has a commercial arrangement. This makes ritlecitinib available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount.